DrugPatentWatch Database Preview
Global Blood Theraps Company Profile
» See Plans and Pricing
What is the competitive landscape for GLOBAL BLOOD THERAPS, and what generic alternatives to GLOBAL BLOOD THERAPS drugs are available?
GLOBAL BLOOD THERAPS has one approved drug.
There are seven US patents protecting GLOBAL BLOOD THERAPS drugs.
There are one hundred and seventy-two patent family members on GLOBAL BLOOD THERAPS drugs in thirty-two countries.
Summary for Global Blood Theraps
International Patents: | 172 |
US Patents: | 7 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Global Blood Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 10,493,035 | Start Trial | Y | Start Trial | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 10,722,502 | Start Trial | Y | Start Trial | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 10,017,491 | Start Trial | Y | Start Trial | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 9,447,071 | Start Trial | Y | Y | Start Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Global Blood Theraps Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2019275607 | Start Trial |
South Korea | 101971385 | Start Trial |
Taiwan | I695830 | Start Trial |
Hungary | E035069 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.